179 related articles for article (PubMed ID: 23709114)
1. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.
Madaras L; Baranyák Z; Kulka J; Szász AM; Kovács A; Lan PH; Székely B; Dank M; Nagy T; Kiss O; Harsányi L; Barbai T; Kenessey I; Tőkés AM
Pathol Oncol Res; 2013 Oct; 19(4):723-9. PubMed ID: 23709114
[TBL] [Abstract][Full Text] [Related]
2. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
3. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
5. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
6. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of triple-negative breast cancer in Taiwanese women.
Yao-Lung K; Dar-Ren C; Tsai-Wang C
Int J Clin Oncol; 2011 Oct; 16(5):500-5. PubMed ID: 21455625
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Ki67 and histological grade in breast cancer patients treated with preoperative chemotherapy.
Petric M; Martinez S; Acevedo F; Oddo D; Artigas R; Camus M; Sanchez C
Asian Pac J Cancer Prev; 2014; 15(23):10277-80. PubMed ID: 25556461
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract][Full Text] [Related]
10. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer.
Mouh FZ; Slaoui M; Razine R; El Mzibri M; Amrani M
Breast Cancer (Auckl); 2020; 14():1178223420906428. PubMed ID: 32425539
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.
Kneubil MC; Brollo J; Botteri E; Curigliano G; Rotmensz N; Goldhirsch A; Lohsiriwat V; Manconi A; Martella S; Santillo B; Petit JY; Rietjens M
Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in young women from a low risk population in Nepal.
Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
Sheridan W; Scott T; Caroline S; Yvonne Z; Vanessa B; David V; Karen G; Stephen C
Breast Cancer Res Treat; 2014 Oct; 147(3):617-29. PubMed ID: 25209005
[TBL] [Abstract][Full Text] [Related]
16. The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer.
Shibuta K; Ueo H; Furusawa H; Komaki K; Rai Y; Sagara Y; Kamada Y; Tamaki N
Breast Cancer; 2011 Oct; 18(4):292-8. PubMed ID: 20571962
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Clinicopathological Features and Molecular Markers in Bahraini Women With Breast Cancer.
AlZaman A; Ali E; Mohamad B; Islam M; AlZaman E; AlZaman Y
Gulf J Oncolog; 2020 Jan; 1(32):19-25. PubMed ID: 32342914
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic features and prognosis of triple negative breast cancer].
Zhou T; Yang L; Ma GM; Li CX; Bai Y; Zhao JA; Wang XL; Geng CZ
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2261-4. PubMed ID: 20095338
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in Bedouin-Arab patients in southern Israel: epidemiologic and biologic features in comparison with Jewish patients.
Lazarev I; Flaschner M; Geffen DB; Ariad S
Asian Pac J Cancer Prev; 2014; 15(18):7533-7. PubMed ID: 25292024
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters.
Lengare PV; Sinai Khandeparkar SG; Joshi AR; Gogate BP; Solanke SG; Gore SH
Indian J Pathol Microbiol; 2020; 63(3):376-381. PubMed ID: 32769325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]